✦ LIBER ✦

Preclinical pharmacokinetics, pharmacodynamics, and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates

✍ Scribed by Sean K Kelley; Thomas Gelzleichter; Dong Xie; Wyne P Lee; Walter C Darbonne; Ferhan Qureshi; Kim Kissler; Ezogelin Oflazoglu; Iqbal S Grewal

Book ID: 110009217
Publisher: Nature Publishing Group
Year: 2006
Tongue: English
Weight: 204 KB
Volume: 148
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0706828

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Preclinical pharmacokinetics, pharmacody

Preclinical pharmacokinetics, pharmacodynamics and activity of a humanized anti-CD40 antibody (SGN-40) in rodents and non-human primates

✍ S K Kelley; T Gelzleichter; D Xie; W P Lee; W C Darbonne; F Qureshi; K Kissler; 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 52 KB

Development, validation and application

Development, validation and application of ELISAs for pharmacokinetic and HACA assessment of a chimeric anti-CD40 monoclonal antibody in human serum

✍ F. Chowdhury; A.L. Tutt; C. Chan; M. Glennie; P.W. Johnson 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 347 KB

Safety Profile, Pharmacokinetics, and Ph

Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients

✍ T.L. Pruett; R.W. McGory; F.H. Wright; M.D. Pescovitz; H. Yang; J.B. McClain 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 448 KB

1201 ORAL Early Studies of the Safety, P

1201 ORAL Early Studies of the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Anti-tumour Activity of the Humanized Monoclonal Antibody (huMAb) Anti-EGFL7 (MEGF0444A) Alone and in Combination With Bevacizumab (Bev) With and Without Paclitaxel (Pac) in Patients (pts) With Advanced Cancer

✍ L. Rosen; P. Munster; S. Bai; P. Hegde; J. Fredrickson; R. Funke; I. Chang; D. C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB